COST-EFFECTIVENESS OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INCLUDING HERD PROTECTION IN TURKEY

被引：2
|
作者：
Turel, O. [1 ]
McIntosh, D.
Bakir, M. [1 ]
机构：
[1] Marmara Univ, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66470-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A436 / A436
页数：1
相关论文
共 50 条
  • [41] Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases
    Rivera-Olivero, Ismar A.
    del Nogal, Berenice
    Fuentes, Mariana
    Cortez, Rossana
    Bogaert, Debby
    Hermans, Peter W. M.
    de Waard, Jacobus H.
    VACCINE, 2014, 32 (31) : 4006 - 4011
  • [42] A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
    Myint Tin Tin Htar
    Harish Madhava
    Paul Balmer
    Dina Christopoulou
    Damianos Menegas
    Eric Bonnet
    Advances in Therapy, 2013, 30 : 748 - 762
  • [43] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Yeh, Sylvia H.
    London, Arnold
    Sidhu, Mohinder S.
    Patterson, Scott
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1086 - 1091
  • [44] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [45] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787
  • [46] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [47] Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants
    Rozenbaum, Mark H.
    Huang, Liping
    Perdrizet, Johnna
    Cane, Alejandro
    Arguedas, Adriano
    Hayford, Kyla
    Tort, Maria J.
    Chapman, Ruth
    Dillon-Murphy, Desmond
    Snow, Vincenza
    Chilson, Erica
    Farkouh, Raymond A.
    VACCINE, 2024, 42 (03) : 573 - 582
  • [48] Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
    Rey-Ares, Lucila
    Averin, Ahuva
    Mac Mullen, Mercedes
    Hariharan, Dhwani
    Atwood, Mark
    Carballo, Carolina
    Huang, Liping
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (06) : 1235 - 1251
  • [49] COST-EFFECTIVENESS OF THE 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE VS 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR A./ULTS IN ARGENTINA
    Mac Mullen, M.
    Carballo, C.
    Seyahian, E.
    VALUE IN HEALTH, 2022, 25 (12) : S132 - S132
  • [50] Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination
    Chen, C.
    Beutels, P.
    Newall, A. T.
    VACCINE, 2018, 36 (16) : 2057 - 2060
12345